Azithromycin for Injection
Name:Azithromycin for Injection
【Approval Number】State Drug Administration ：H20067807
This product is indicated for patients with the following infections community-acquired pneumonia caused by sensitive pathogens such as Chlamydia pneumoniae, Haemophilus influenzae, Legionella pneumophila, Catamorax, Mycoplasma pneumoniae, Staphylococcus aureus or Streptococcus pneumoniae, and for whom intravenous administration is required for initiation of therapy.
Pelvic inflammatory disease
Patients with Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma hominis who require intravenous administration for initiation of therapy. If anaerobic infections are suspected, an anti-anaerobic agent should be added to the treatment with this product.